Provided by Tiger Fintech (Singapore) Pte. Ltd.

XUANZHUBIO-B

29.000
+2.70010.27%
Volume:2.39M
Turnover:61.60M
Market Cap:15.02B
PE:- -
High:29.000
Open:26.100
Low:23.820
Close:26.300
52wk High:31.000
52wk Low:23.820
Shares:517.95M
HK Float Shares:160.70M
Volume Ratio:0.16
T/O Rate:1.49%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:16.28
PE(LYR):- -
PS:430.94

Loading ...

Xuanzhu Biopharmaceutical Soars 154% in Hong Kong Debut

MT Newswires Live
·
Oct 15

XUANZHUBIO-B (02575) Targets to Become Hong Kong's New Biopharma Benchmark with "Dual-Wheel Drive + Three Commercialization Pillars" Strategy

Stock News
·
Oct 15

Stock Track | XUANZHUBIO-B Skyrockets 163.79% on Hong Kong Stock Exchange Debut, Reflecting Strong Investor Demand

Stock Track
·
Oct 15

Hong Kong Indexes Open Higher with Hang Seng Up 1.08%, Tech Index Gains 1.31%; Tech and Gold Stocks Rise Broadly, Chinese Brokerages Active, XUANZHUBIO-B Surges 154% on Debut

Deep News
·
Oct 15

Shares of Xuanzhu Biopharmaceutical Set to Open at HK$29.46 Each in Hong Kong Debut VS Offer Price HK$11.60 Apiece

THOMSON REUTERS
·
Oct 15

Xuanzhu Biopharmaceutical Raises HK$701 Million from Hong Kong IPO Ahead of Trading Debut

MT Newswires Live
·
Oct 15

Hong Kong Stock Investment Journal | October 15

Stock News
·
Oct 15

XUANZHUBIO-B (02575): Offering Price Set at HK$11.6 Per Share, Hong Kong Public Offering Oversubscribed by 4,908.33 Times

Stock News
·
Oct 14

China's Xuanzhu Biopharmaceutical Soars 158% in Hong Kong Grey Market

Tiger Newspress
·
Oct 14

Hong Kong Stocks Begin Week in Red; Xuanzhu Biopharmaceutical Launches Hong Kong IPO

MT Newswires Live
·
Oct 06

Hong Kong Stock Movement | SIHUAN PHARM (00460) Surges Over 4% Again as XUANZHUBIO Launches IPO Today, Company's "Dongyan" Product Receives Market Approval

Stock News
·
Oct 06

BRIEF-Xuanzhu Biopharmaceutical Announces Offer Price Under Global Offering Of Hk$11.60 Per H Share

Reuters
·
Oct 06